Population Pharmacokinetic Model Characterizing 24-Hour Variation in the Pharmacokinetics of Oral and Intravenous Midazolam in Healthy Volunteers.
about
Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African children.Role of Cytochrome P450 3A4 and 1A2 Phenotyping in Patients with Advanced Non-small-Cell Lung Cancer Receiving Erlotinib Treatment.Hypoalbuminaemia and decreased midazolam clearance in terminally ill adult patients, an inflammatory effect?Identifying 24 h variation in the pharmacokinetics of levofloxacin: a population pharmacokinetic approach.Highly variable absorption of clavulanic acid during the day: a population pharmacokinetic analysis.LC-MS/MS Method for Simultaneous Quantification of Dexmedetomidine, Dezocine, and Midazolam in Rat Plasma and Its Application to Their Pharmacokinetic Study.
P2860
Population Pharmacokinetic Model Characterizing 24-Hour Variation in the Pharmacokinetics of Oral and Intravenous Midazolam in Healthy Volunteers.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Population Pharmacokinetic Mod ...... dazolam in Healthy Volunteers.
@en
Population Pharmacokinetic Mod ...... dazolam in Healthy Volunteers.
@nl
type
label
Population Pharmacokinetic Mod ...... dazolam in Healthy Volunteers.
@en
Population Pharmacokinetic Mod ...... dazolam in Healthy Volunteers.
@nl
prefLabel
Population Pharmacokinetic Mod ...... dazolam in Healthy Volunteers.
@en
Population Pharmacokinetic Mod ...... dazolam in Healthy Volunteers.
@nl
P2093
P2860
P356
P1476
Population Pharmacokinetic Mod ...... dazolam in Healthy Volunteers.
@en
P2093
A van Rongen
F van Oosterhout
H van Meir
J Burggraaf
J H Meijer
J den Hartigh
L Kervezee
P2860
P304
P356
10.1002/PSP4.12007
P577
2015-07-24T00:00:00Z